ANTIPYRINE AS A MODEL-DRUG TO STUDY HEPATIC DRUG-METABOLIZING CAPACITY

被引：127

作者：

POULSEN, HE ^{[1
]}

LOFT, S ^{[1
]}

机构：

[1] RIGSHOSP,DEPT MED A,DK-2100 COPENHAGEN O,DENMARK

来源：

JOURNAL OF HEPATOLOGY | 1988年 / 6卷 / 03期

关键词：

D O I：

10.1016/S0168-8278(88)80057-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：374 / 382

页数：9

共 64 条

[1]

ANDREASEN PB, 1974, CLIN PHARMACOL THER, V16, P1059

[2]

ANDREASEN PB, 1974, EUR J CLIN INVEST, V4, P129

[3] THE EFFECT OF VERAPAMIL ON ANTIPYRINE PHARMACOKINETICS AND METABOLISM IN MAN [J].

BACH, D ;

BLEVINS, R ;

KERNER, N ;

RUBENFIRE, M ;

EDWARDS, DJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (06) :655-659

[4]

BACH DJ, 1983, BR J CLIN PHARM, V16, P497

[5] FAMILY STUDY OF ANTIPYRINE CLEARANCE [J].

BLAIN, PG ;

MUCKLOW, JC ;

WOOD, P ;

ROBERTS, DF ;

RAWLINS, MD .

BRITISH MEDICAL JOURNAL, 1982, 284 (6310) :150-152

[6] HEPATIC DRUG-METABOLISM AND PHYSICAL-FITNESS [J].

BOEL, J ;

ANDERSEN, LB ;

RASMUSSEN, B ;

HANSEN, SH ;

DOSSING, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (01) :121-126

[7] COMPARISON OF THE INVIVO AND INVITRO RATES OF FORMATION OF THE 3 MAIN OXIDATIVE METABOLITES OF ANTIPYRINE IN MAN [J].

BOOBIS, AR ;

BRODIE, MJ ;

KAHN, GC ;

TOVERUD, EL ;

BLAIR, IA ;

MURRAY, S ;

DAVIES, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 12 (06) :771-777

[8] CHOLIC-ACID CONJUGATION TEST AND QUANTITATIVE LIVER-FUNCTION IN ACUTE LIVER-FAILURE [J].

BREMMELGAARD, A ;

RANEK, L ;

BAHNSEN, M ;

ANDREASEN, PB ;

CHRISTENSEN, E .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 (06) :797-802

[9]

BRODIE BB, 1950, J PHARMACOL EXP THER, V98, P97

[10] DILTIAZEM TREATMENT IMPAIRS HEPATIC DRUG OXIDATION - STUDIES OF ANTIPYRINE [J].

CARRUM, G ;

EGAN, JM ;

ABERNETHY, DR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (02) :140-143

← 1 2 3 4 5 6 7 →